SCHEMBL8200029

SCHEMBL8200029

CC(=O)c1ccc(-c2c(Cl)n[nH]c2-c2ccc([S+](C)[O-])cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XDH P47989 1/20 0.39
PRKAB2 O43741 1/20 0.36
PRKAG1 P54619 1/20 0.36
PRKAA2 P54646 1/20 0.36
PRKAA1 Q13131 1/20 0.36
PRKAG3 Q9UGI9 1/20 0.36
PRKAG2 Q9UGJ0 1/20 0.36
PRKAB1 Q9Y478 1/20 0.36
BRD4 O60885 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 2/20 0.33
FYN P06241 2/20 0.33
HSD17B1 P14061 1/20 0.33
AURKA O14965 1/20 0.33
MAP4K4 O95819 1/20 0.33
PAK4 O96013 1/20 0.33
ABL1 P00519 1/20 0.33
RET P07949 1/20 0.33
LTK P29376 1/20 0.33
KDR P35968 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8637992 0.82 MAPK14 (0.46) ALKRPS6KA3MAPK1NPSR1MAPK13
SCHEMBL8194840 0.75 MAPT (0.37) MAPTALDH1A1LMNAMAPK1NPSR1
SCHEMBL31256698 0.74 MAPK1 (0.47) XDHSMN1; SMN2MAPTHSD17B1ALDH1A1
SCHEMBL8196956 0.66 CA2 (0.36) LMNA
SCHEMBL8640165 0.66 RPS6KA3 (0.33) MAP4K4RETKDRGSK3BLIMK1
SCHEMBL9664436 0.66 HPGD (0.68) SMN1; SMN2MAPTALDH1A1LMNAMAPK1
SCHEMBL8637748 0.65 PTGS2 (0.56)
SCHEMBL8642584 0.65 BRD4 (0.43) XDHBRD4SMN1; SMN2MAPTFYN
SCHEMBL8201683 0.64 MAPK14 (0.44) MAPTRPS6KA3MAPK1NPSR1MAPK13
SCHEMBL8196073 0.64 ENPP1 (0.35) RPS6KA3LMNAMAPK1NPSR1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018741-A2 PYRAZOLE COMPOUNDS AS COX-2 INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-06 WO disclosed